Clarivate (NYSE:CLVT) Releases FY25 Earnings Guidance

Clarivate (NYSE:CLVT) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.60-$0.70 for the period, compared to the consensus estimate of $0.73. The company issued revenue guidance of $2.28-$2.40 billion, compared to the consensus revenue estimate of $2.53 billion. Clarivate also updated its FY 2025 guidance to 0.600-0.700 EPS.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Barclays lowered their price objective on Clarivate from $5.00 to $4.00 and set an “underweight” rating for the company in a research note on Thursday, November 7th. William Blair downgraded shares of Clarivate from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 6th. Finally, Royal Bank of Canada decreased their price target on shares of Clarivate from $7.00 to $6.00 and set a “sector perform” rating on the stock in a report on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Clarivate currently has a consensus rating of “Hold” and an average target price of $7.10.

Clarivate Price Performance

Shares of NYSE CLVT traded up $0.06 during mid-day trading on Thursday, hitting $4.82. 3,940,816 shares of the company’s stock traded hands, compared to its average volume of 5,161,279. The company has a market capitalization of $3.42 billion, a P/E ratio of -2.42 and a beta of 1.17. The company has a debt-to-equity ratio of 0.84, a current ratio of 0.88 and a quick ratio of 0.88. The company’s 50-day moving average is $5.14 and its two-hundred day moving average is $5.81. Clarivate has a 1 year low of $4.22 and a 1 year high of $9.07.

Clarivate announced that its board has authorized a share buyback program on Monday, December 16th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 12.8% of its shares through open market purchases. Shares repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.

Insider Buying and Selling

In related news, Director Michael J. Angelakis bought 765,000 shares of the stock in a transaction that occurred on Friday, November 22nd. The stock was bought at an average cost of $5.19 per share, for a total transaction of $3,970,350.00. Following the purchase, the director now directly owns 3,465,000 shares of the company’s stock, valued at approximately $17,983,350. This trade represents a 28.33 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 22.77% of the stock is owned by insiders.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.